ASSOCIATION FOR MOLECULAR PATHOLOG… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

LAUREN S MENSER

Phone

3016347987

Tax Period

2024-01-01 to 2024-12-31

ASSOCIATION FOR MOLECULAR PATHOLOGY INC, founded in 1999, is a community nonprofit in the Education sector that reported $6.3M in total revenue in fiscal year 2024. Expenses of $7.5M exceeded revenue, resulting in a 19% operating deficit.

Mission

ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE.

Program Service Accomplishments

Program 1

Expenses: $2,845,984 Revenue: $4,154,655

SCIENTIFIC SYMPOSIA AND MEETINGS - SEE SCHEDULE O FOR COMPLETE DESCRIPTION

Program 2

Expenses: $320,975 Revenue: $467,403

COMMUNICATION & OUTREACH: MEMBERSHIP SERVICES - WEBSITE, NEWSLETTERS, ETC.PROMOTE GENERAL EFFECTIVENESS AND PROVIDE A FORUM FOR DISCUSSION AND A MEANS OF EXCHANGING INFORMATION.

Program 3

Expenses: $558,685 Revenue: $72,723

INNOVATION AND IMPROVED PATIENT CARE (IIPC) - SEE SCHEDULE O FOR COMPLETE DESCRIPTIONIIPC WORKS TO FOSTER INNOVATION TO IMPROVE PATIENT CARE AND PATIENT OUTCOMES THROUGH PROGRAMS THAT INCLUDE ISSUING MANUSCRIPTS, CLINICAL PRACTICE GUIDELINES, REPORTS, AND OVERSIGHT OF JMD'S STRATEGIC DIRECTION.THE JOURNAL OF MOLECULAR DIAGNOSTICSTHIS IS THE OFFICIAL JOURNAL OF AMP. MONTHLY PUBLICATION BEGAN IN JANUARY 2020. THESE ISSUES HAVE ORIGINAL, HIGH-QUALITY MANUSCRIPTS ON SCIENTIFIC ADVANCES IN THE TRANSLATION AND VALIDATION OF MOLECULAR DISCOVERIES IN MEDICINE INTO THE CLINICAL DIAGNOSTIC SETTING, AND THE DESCRIPTION AND APPLICATION OF TECHNOLOGICAL ADVANCES IN THE FIELD OF MOLECULAR DIAGNOSTIC MEDICINE.EVERY PUBLISHED MANUSCRIPT IS SCIENTIFICALLY PEER REVIEWED.JMD IS JOINTLY OWNED WITH THE AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY (ASIP) 94-6079945. STARTING IN 2011, ELSEVIER BEGAN PUBLISHING JMD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,047,214

Program Service Revenue $4,841,831

Investment Income $388,344

Other Revenue $0

TOTAL REVENUE $6,277,389

Expense Breakdown

Grants Paid $37,425

Salaries & Benefits $2,756,879

Fundraising Expenses $0

Program Expenses $5,588,295

Other Expenses $4,696,891

TOTAL EXPENSES $7,491,195

Year-over-Year Comparison

	2024	2023	Change
Revenue	$6,277,389	$6,367,441	0.0%
Expenses	$7,491,195	$6,462,888	+0.2%
Net Income	$-1,213,806	$-95,447	+11.7%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

411

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$440,550

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARIA E ARCILA MD	PRESIDENT (1/1-11/23/24)	2.00	Officer Director	$0	$0	$0
LAURA J TAFE MD	PAST PRES & NOMINATING (1/1-11/23/24)	2.00	Officer Director	$0	$0	$0
JANE S GIBSON MS PHD	PRES ELECT:AWARD&STRAT (1/1-11/23/24)	2.00	Officer Director	$0	$0	$0
YASSMINE MN AKKARI PHD	SECRETARY-TREASURER	2.00	Officer Director	$0	$0	$0
YAOLIN ZHOU MD	MEM AFFAIRS COMM (1/1-11/23/24)	2.00	Director	$0	$0	$0
ERIC KONNICK MD MS	PROFESSIONAL RELATIONS COM	2.00	Director	$0	$0	$0
MARJORIE DAVID MD MS	TRAINING & EDUCATION COMM	2.00	Director	$0	$0	$0
KRISTEN ST GEORGE MAPPSC PHD	INFECT DIS SUBDIV (1/1/-11/23/24)	2.00	Director	$0	$0	$0
SUSAN H HSIAO MD PHD	CLINICAL PRAC COMM (1/1-11/23/24)	2.00	Director	$0	$0	$0
MATTHEW LEBO PHD	GENETICS SUBDIV CHAIR (1/1-11/23/24)	2.00	Director	$0	$0	$0
ANNETTE LEON PHD MSC	INFO SUBDIV CHAIR (1/1-11/23/24)	2.00	Director	$0	$0	$0
JAY PATEL MD	ECONOMIC AFFAIRS COMMITTEE	2.00	Director	$0	$0	$0
JONATHAN NOWAK MD PHD	PROG COMM CHAIR (1/1-11/23/24)	2.00	Director	$0	$0	$0
PATRICIA TSANG MD	PUBLICATION/COMMUNICATION	2.00	Director	$0	$0	$0
RENA R XIAN MD	HEMATOPATHOLOGY SUBDIVISIO	2.00	Director	$0	$0	$0
ANTHONY N SNOW MD	SOLID TUMORS SUBDIVISION C	2.00	Director	$0	$0	$0
RAMI MAHFOUZ MD MPH	INTERNATIONAL AFFAIRS COMM	2.00	Director	$0	$0	$0
ADAM FISCH MD PHD	EARLY CAREER MEMBER	2.00	Director	$0	$0	$0
PANIEH TERRAF PHD	EARLY CAREER MEMBER 1/1-11/23/24)	2.00	Director	$0	$0	$0
JANE S GIBSON MS PHD	PRESIDENT (START 11/24/24)	2.00	Officer Director	$0	$0	$0
AARON BOSSLER MD PHD	PRES ELECT: AWAR&STRAT(START 11/24/24)	2.00	Officer Director	$0	$0	$0
MARIA E ARCILA MD	PAST PRES/NOM CHAIR (START 11/24/24)	2.00	Officer Director	$0	$0	$0
ALANNA CHURCH MD	CLIN PRAC COMM CHAIR (START 11/24/24)	2.00	Director	$0	$0	$0
EMILIA CALVARESI MD PHD	EARLY CAREER REPR (START 11/24/24)	2.00	Director	$0	$0	$0
JENNIFER MORRISSETTE PHD	MEM AFF COMM CHAIR (START 11/24/24)	2.00	Director	$0	$0	$0
SOMAK ROY MD	PROG COMM CHAIR (START 11/24/24)	2.00	Director	$0	$0	$0
KRISTY CROOKS PHD	GEN SUBDIV CHAIR (START 11/24/24)	2.00	Director	$0	$0	$0
JOSEPH YAO MD	INF DIS SUBDIV CHAIR (START 11/24/24)	2.00	Director	$0	$0	$0
JULIE HIRSCHHORN PHD	INFO SUBDIV CHAIR (START 11/24/24)	2.00	Director	$0	$0	$0
MARY STEELE WILLIAMS MNA MT ASCPSM	EXECUTIVE DIRECTOR (THRU 1/2/24)	40.00	Officer	$52,854	$1,859	$54,713
LAUREN S MENSER	CHIEF EXECUTIVE OFFICER-START 1/3/24	40.00	Officer	$342,611	$43,226	$385,837
ROBYN TEMPLE-SMOLKIN	DIR CLINICAL/SCIENTIFIC AF	40.00	Highest	$160,987	$43,316	$204,303
SARA HAMILTON	DIRECTOR OF MEETINGS & EXH	40.00	Highest	$156,152	$25,112	$181,264
ERIKO CLEMENTS	DIRECTOR OF EDUCATION PROG	40.00	Highest	$141,177	$36,713	$177,890
MICHELE ZINK	DIRECTOR OF GOVERNANCE & O	40.00	Highest	$141,500	$23,726	$165,226
ANNA MARIA SCRIMENTI	DIR PUBLIC POLICY & ADVOCACY	40.00	Highest	$145,099	$23,457	$168,556

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$6,277,389	$7,491,195	$15,519,539	$-1,213,806
2023	$6,367,441	$6,462,888	$16,076,546	$-95,447
2022	$8,898,005	$5,788,053	$14,807,371	$3,109,952
2021	$4,277,473	$4,600,144	$16,458,574	$-322,671
2020	$3,937,280	$4,415,312	$15,790,970	$-478,032
2019	$6,294,779	$5,590,657	$15,492,214	$704,122
2018	$5,985,958	$5,050,953	$13,414,564	$935,005

ASSOCIATION FOR MOLECULAR PATHOLOGY INC